These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 364727)
21. Specific immunosuppression of cardiac allograft rejection in rats. Jenkins AM; Woodruff MF Transplant Proc; 1973 Mar; 5(1):727-32. PubMed ID: 4144462 [No Abstract] [Full Text] [Related]
22. Comparison of kidney, composite tissue, and skin allograft survival in rats prolonged by donor blood and concomitant limited cyclosporine. Hewitt CW; Black KS; Stenger JA; Go C; Achauer BM; Martin DC Transplant Proc; 1988 Jun; 20(3 Suppl 3):1110-3. PubMed ID: 3291221 [No Abstract] [Full Text] [Related]
23. A comparison among the effects of donor-specific whole blood, bone marrow, and spleen leukocytes on allograft survival when combined with cyclosporine. Gyopar AF; Loertscher R; Guttman RD; Tchervenkov JI Transplantation; 1993 May; 55(5):1199-202. PubMed ID: 8497904 [No Abstract] [Full Text] [Related]
24. Donor specific transfusions: a five-year experience with alternative protocols. Norman DJ; Henell K; Fletcher L; Barry J Transplant Proc; 1987 Feb; 19(1 Pt 3):2252-4. PubMed ID: 3274504 [No Abstract] [Full Text] [Related]
26. Is donor-specific blood transfusion effective for strong minor histocompatibility antigen barriers? Hara MH; Suzuki H; Shibata K; Tanigawa M; Sekiya R; Matsuzaki Y; Onitsuka T; Koga Y; Yamashita A; Miyamoto M; Suzuki S; Amemiya H; Kimura H Transplant Proc; 1996 Jun; 28(3):1268-9. PubMed ID: 8658654 [No Abstract] [Full Text] [Related]
27. Prolonged survival of hepatic and cardiac allografts by i.v. injection of donor spleen cells following splenectomy in rats: possible mechanisms involved in tolerance induced by intraportal injection of donor antigens. Nagano H; Monden M; Gotoh M; Tanigawa T; Nakano Y; Tono T; Mori T Transplant Proc; 1993 Feb; 25(1 Pt 1):352-3. PubMed ID: 8438331 [No Abstract] [Full Text] [Related]
28. Different response of intestinal and cardiac allografts to pretreatment with UV-B irradiated donor-specific leukocytes (DL) or DL alone. Gundlach M; Oluwole SF; Pohland CC; Broelsch CE; Hardy MA Transplant Proc; 1996 Oct; 28(5):2482-3. PubMed ID: 8907913 [No Abstract] [Full Text] [Related]
29. Prolongation of skin allograft survival by combined feeding of donor spleen cells and cyclosporine in mice. Lu X; Zhou L; Chen S Transplant Proc; 2004 Oct; 36(8):2429-31. PubMed ID: 15561269 [TBL] [Abstract][Full Text] [Related]
30. Induction of long-term rat renal allograft survival: a specific synergistic effect of limited pretransplant cyclosporine combined with multiple nonspecific blood transfusions. Martin DC; Hewitt CW; Black KS; Reyes M; Go C Transplant Proc; 1987 Feb; 19(1 Pt 1):462-3. PubMed ID: 3274807 [No Abstract] [Full Text] [Related]
31. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage. Tchervenkov JI; Cofer BR; Davies C; Alexander JW Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575 [TBL] [Abstract][Full Text] [Related]
32. Skin allograft survival following intrathymic injection of donor bone marrow. Cober SR; Randolph MA; Lee WP J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320 [TBL] [Abstract][Full Text] [Related]
33. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival. Kanatani T; Lanzetta M; Owen E; Matsumoto T; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA Transplant Proc; 2005 Jun; 37(5):2382-4. PubMed ID: 15964421 [TBL] [Abstract][Full Text] [Related]
34. Synergistic effect of FK 506 and donor-specific blood transfusion on rat skin but not on composite tissue (limb) allograft survival. Kuroki H; Bean MA; Ikuta Y; Burgess EM Transplant Proc; 1991 Dec; 23(6):3282-4. PubMed ID: 1721436 [No Abstract] [Full Text] [Related]
35. Speculation on the pathogenesis of prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells. Lowry RP; Kenick S; Lisbona R Transplant Proc; 1987 Aug; 19(4):3451-3. PubMed ID: 2956743 [No Abstract] [Full Text] [Related]
36. Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection. Goss JA; Nakafusa Y; Yu S; Flye MW Transplant Proc; 1993 Feb; 25(1 Pt 1):286-8. PubMed ID: 8438302 [No Abstract] [Full Text] [Related]
37. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767 [TBL] [Abstract][Full Text] [Related]
38. Prolongation of skin allograft survival in immunosuppressed mice by multiple transfusions of nonspecific blood. Okazaki H; Maki T; Wood ML; Monaco AP Transplantation; 1980 Apr; 29(4):341-4. PubMed ID: 6989053 [No Abstract] [Full Text] [Related]
39. Enhanced allograft survival by combined active and passive immunization. Requirement of both erythrocytes and leukocytes. Baldwin WM; Null WL; Notis-McConarty J; Tilney NL Transplantation; 1978 Mar; 25(3):121-5. PubMed ID: 347646 [No Abstract] [Full Text] [Related]
40. Role of reconstituted passenger leukocytes on the induction of tolerance in rat liver transplantation. Chiba S; Goto S; Shimizu Y; Vari F; Lord R; Edwards-Smith C; Ochiai T; Isono K Transplant Proc; 1997; 29(1-2):1160-1. PubMed ID: 9123251 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]